Epigenomics AG (FRA:ECX)
1.200
-0.200 (-14.29%)
Feb 23, 2026, 8:09 AM CET
7.14% (1Y)
| Market Cap | 1.23M +75.4% |
| Revenue (ttm) | 4.00K -97.1% |
| Net Income | -2.76M |
| EPS | -3.15 |
| Shares Out | 876.95K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 664 |
| Open | 1.200 |
| Previous Close | 1.400 |
| Day's Range | 1.200 - 1.200 |
| 52-Week Range | 0.500 - 1.590 |
| Beta | 0.77 |
| RSI | 61.12 |
| Earnings Date | Mar 25, 2026 |